Status:
RECRUITING
Evaluation of Severity in Juvenile and Adult-onset Dermatomyositis
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Dermatomyositis
Eligibility:
All Genders
Brief Summary
Dermatomyositis (DM) are rare and heterogeneous systemic autoimmune diseases, characterized by the association of muscle inflammation, skin inflammation and vasculopathy. DM concern both adults and ch...
Eligibility Criteria
Inclusion
- Patient with dermatomyositis according to 2017 American College of Rheumatology (ACR)/ European Alliance of Associations for Rheumatology (EULAR) classification
Exclusion
- Patient with cancer-associated dermatomyositis (within 3 years before or after diagnosis of dermatomyositis)
- Patient with antisynthetase syndrome
Key Trial Info
Start Date :
October 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06004817
Start Date
October 1 2023
End Date
September 30 2024
Last Update
August 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Nancy
Nancy, France